Cite
APA Citation
Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Brochet, B., Naismith, R. T., Traboulsee, A., Wolinsky, J. S., Belachew, S., Koendgen, H., Levesque, V., Manfrini, M., Model, F., Hubeaux, S., Mehta, L., & Montalban, X. (2020). five years of ocrelizumab in relapsing multiple sclerosis. Neurology, 95, . http://access.bl.uk/ark:/81055/vdc_100112671140.0x00002a